Search by Drug Name or NDC

    NDC 69488-0010-61 PLUVICTO 27 mCi/mL Details

    PLUVICTO 27 mCi/mL

    PLUVICTO is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Advanced Accelerator Applications USA, Inc. The primary component is LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN.

    Product Information

    NDC 69488-0010
    Product ID 69488-010_fc9c3c57-55b4-4586-a8c4-fde74e46a895
    Associated GPIs 21600045802020
    GCN Sequence Number 083207
    GCN Sequence Number Description Lu-177 vipivotide tetraxetan VIAL 27 MCI/ML INTRAVEN
    HIC3 V1G
    HIC3 Description RADIOACTIVE THERAPEUTIC AGENTS
    GCN 52100
    HICL Sequence Number 047914
    HICL Sequence Number Description LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
    Brand/Generic Brand
    Proprietary Name PLUVICTO
    Proprietary Name Suffix n/a
    Non-Proprietary Name lutetium Lu 177 vipivotide tetraxetan
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 27
    Active Ingredient Units mCi/mL
    Substance Name LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
    Labeler Name Advanced Accelerator Applications USA, Inc
    Pharmaceutical Class Radioligand Activity [MoA], Radioligand Therapeutic Agent [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215833
    Listing Certified Through 2024-12-31

    Package

    NDC 69488-0010-61 (69488001061)

    NDC Package Code 69488-010-61
    Billing NDC 69488001061
    Package 1 VIAL, GLASS in 1 PACKAGE (69488-010-61) / 7.5 mL in 1 VIAL, GLASS
    Marketing Start Date 2022-03-23
    NDC Exclude Flag N
    Pricing Information N/A